KDDL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 8, 2025, 8:14 pm

Competitors of KDDL Ltd

All Competitor Stocks of KDDL Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:15 am

Below is a detailed analysis of the quarterly data for KDDL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 465.00 Cr.. The value appears strong and on an upward trend. It has increased from 420.00 Cr. (Mar 2025) to 465.00 Cr., marking an increase of 45.00 Cr..
• For Expenses, as of Jun 2025, the value is 397.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 355.00 Cr. (Mar 2025) to 397.00 Cr., marking an increase of 42.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 68.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.00 Cr. (Mar 2025) to 27.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
• For Tax %, as of Jun 2025, the value is 32.00%. The value appears to be increasing, which may not be favorable. It has increased from 28.00% (Mar 2025) to 32.00%, marking an increase of 4.00%.
• For Net Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 32.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 16.30. The value appears strong and on an upward trend. It has increased from 16.20 (Mar 2025) to 16.30, marking an increase of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:32 pm

Growth

Last Updated: September 5, 2025, 8:55 am

Balance Sheet

Last Updated: September 10, 2025, 1:56 pm

Below is a detailed analysis of the balance sheet data for KDDL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2024) to 12.00 Cr., marking a decrease of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 903.00 Cr.. The value appears strong and on an upward trend. It has increased from 721.00 Cr. (Mar 2024) to 903.00 Cr., marking an increase of 182.00 Cr..
• For Borrowings, as of Mar 2025, the value is 453.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 250.00 Cr. (Mar 2024) to 453.00 Cr., marking an increase of 203.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 722.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 652.00 Cr. (Mar 2024) to 722.00 Cr., marking an increase of 70.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,090.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,636.00 Cr. (Mar 2024) to 2,090.00 Cr., marking an increase of 454.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 603.00 Cr.. The value appears strong and on an upward trend. It has increased from 350.00 Cr. (Mar 2024) to 603.00 Cr., marking an increase of 253.00 Cr..
• For CWIP, as of Mar 2025, the value is 48.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2024) to 48.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,433.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,234.00 Cr. (Mar 2024) to 1,433.00 Cr., marking an increase of 199.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,090.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,636.00 Cr. (Mar 2024) to 2,090.00 Cr., marking an increase of 454.00 Cr..

Notably, the Reserves (903.00 Cr.) exceed the Borrowings (453.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for KDDL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 81.90. This value is within the healthy range. It has increased from 42.18 (Mar 23) to 81.90, marking an increase of 39.72.
• For Diluted EPS (Rs.), as of Mar 24, the value is 81.90. This value is within the healthy range. It has increased from 42.18 (Mar 23) to 81.90, marking an increase of 39.72.
• For Cash EPS (Rs.), as of Mar 24, the value is 159.72. This value is within the healthy range. It has increased from 99.71 (Mar 23) to 159.72, marking an increase of 60.01.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 581.39. It has increased from 556.19 (Mar 23) to 581.39, marking an increase of 25.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 581.39. It has increased from 556.19 (Mar 23) to 581.39, marking an increase of 25.20.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,101.88. It has increased from 886.75 (Mar 23) to 1,101.88, marking an increase of 215.13.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 219.13. This value is within the healthy range. It has increased from 142.95 (Mar 23) to 219.13, marking an increase of 76.18.
• For PBIT / Share (Rs.), as of Mar 24, the value is 167.70. This value is within the healthy range. It has increased from 103.82 (Mar 23) to 167.70, marking an increase of 63.88.
• For PBT / Share (Rs.), as of Mar 24, the value is 146.93. This value is within the healthy range. It has increased from 84.84 (Mar 23) to 146.93, marking an increase of 62.09.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 108.29. This value is within the healthy range. It has increased from 60.58 (Mar 23) to 108.29, marking an increase of 47.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 81.33. This value is within the healthy range. It has increased from 42.45 (Mar 23) to 81.33, marking an increase of 38.88.
• For PBDIT Margin (%), as of Mar 24, the value is 19.88. This value is within the healthy range. It has increased from 16.12 (Mar 23) to 19.88, marking an increase of 3.76.
• For PBIT Margin (%), as of Mar 24, the value is 15.21. This value is within the healthy range. It has increased from 11.70 (Mar 23) to 15.21, marking an increase of 3.51.
• For PBT Margin (%), as of Mar 24, the value is 13.33. This value is within the healthy range. It has increased from 9.56 (Mar 23) to 13.33, marking an increase of 3.77.
• For Net Profit Margin (%), as of Mar 24, the value is 9.82. This value is within the healthy range. It has increased from 6.83 (Mar 23) to 9.82, marking an increase of 2.99.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 7.38. This value is below the healthy minimum of 8. It has increased from 4.78 (Mar 23) to 7.38, marking an increase of 2.60.
• For Return on Networth / Equity (%), as of Mar 24, the value is 13.98. This value is below the healthy minimum of 15. It has increased from 11.74 (Mar 23) to 13.98, marking an increase of 2.24.
• For Return on Capital Employeed (%), as of Mar 24, the value is 16.10. This value is within the healthy range. It has increased from 14.94 (Mar 23) to 16.10, marking an increase of 1.16.
• For Return On Assets (%), as of Mar 24, the value is 6.25. This value is within the healthy range. It has increased from 4.61 (Mar 23) to 6.25, marking an increase of 1.64.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.16 (Mar 23) to 0.06, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has decreased from 0.27 (Mar 23) to 0.14, marking a decrease of 0.13.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.99. It has decreased from 1.18 (Mar 23) to 0.99, marking a decrease of 0.19.
• For Current Ratio (X), as of Mar 24, the value is 3.59. This value exceeds the healthy maximum of 3. It has increased from 2.73 (Mar 23) to 3.59, marking an increase of 0.86.
• For Quick Ratio (X), as of Mar 24, the value is 2.09. This value exceeds the healthy maximum of 2. It has increased from 1.38 (Mar 23) to 2.09, marking an increase of 0.71.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.22. This value is below the healthy minimum of 4. It has decreased from 0.26 (Mar 23) to 0.22, marking a decrease of 0.04.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 73.25. This value exceeds the healthy maximum of 50. It has increased from 11.80 (Mar 23) to 73.25, marking an increase of 61.45.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 44.88. This value is within the healthy range. It has increased from 6.14 (Mar 23) to 44.88, marking an increase of 38.74.
• For Earning Retention Ratio (%), as of Mar 24, the value is 26.75. This value is below the healthy minimum of 40. It has decreased from 88.20 (Mar 23) to 26.75, marking a decrease of 61.45.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 55.12. This value is within the healthy range. It has decreased from 93.86 (Mar 23) to 55.12, marking a decrease of 38.74.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 10.55. This value is within the healthy range. It has increased from 7.53 (Mar 23) to 10.55, marking an increase of 3.02.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.21. This value is within the healthy range. It has increased from 4.19 (Mar 23) to 6.21, marking an increase of 2.02.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,090.33. It has increased from 1,392.03 (Mar 23) to 3,090.33, marking an increase of 1,698.30.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.22. This value is within the healthy range. It has increased from 1.24 (Mar 23) to 2.22, marking an increase of 0.98.
• For EV / EBITDA (X), as of Mar 24, the value is 11.17. This value is within the healthy range. It has increased from 7.71 (Mar 23) to 11.17, marking an increase of 3.46.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 2.23, marking an increase of 1.08.
• For Retention Ratios (%), as of Mar 24, the value is 26.74. This value is below the healthy minimum of 30. It has decreased from 88.19 (Mar 23) to 26.74, marking a decrease of 61.45.
• For Price / BV (X), as of Mar 24, the value is 4.23. This value exceeds the healthy maximum of 3. It has increased from 2.82 (Mar 23) to 4.23, marking an increase of 1.41.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.23. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 2.23, marking an increase of 1.08.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness